1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Rare disease - Endocrinology

Discussion in 'Pfizer' started by anonymous, Nov 5, 2019 at 4:38 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Any thoughts on this position/division? Thank you in advance.